Tethering identifies fragment that yields potent inhibitors of human caspase-1.
Fahr, B.T., O'Brien, T., Pham, P., Waal, N.D., Baskaran, S., Raimundo, B.C., Lam, J.W., Sopko, M.M., Purkey, H.E., Romanowski, M.J.(2006) Bioorg Med Chem Lett 16: 559-562
- PubMed: 16274992 
- DOI: https://doi.org/10.1016/j.bmcl.2005.10.048
- Primary Citation of Related Structures:  
1RWW, 1RWX - PubMed Abstract: 
Disulfide Tethering was applied to the active site of human caspase-1, resulting in the discovery of a novel, tricyclic molecular fragment that selectively binds in S4. This fragment was developed into a class of potent inhibitors of human caspase-1. Several key analogues determined the optimal distance of the tricycle from the catalytic residues, the relative importance of various features of the tricycle, and the importance of the linker.
Organizational Affiliation: 
Department of Chemistry, Sunesis Pharmaceuticals, 341 Oyster Point Boulevard, South San Francisco, CA 94080, USA. bfahr@sunesis.com